Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Proposed Acquisition of European Medical Testing Subsidiary (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sohm Inc SHMN

SOHM, Inc. is a pharmaceutical manufacturer that produces and markets generic drugs for various treatment categories. The Company is focused on developing, manufacturing and distributing generic, branded generic, private label pharmaceuticals, cosmeceuticals and nutraceutical products. The Company has expertise in various drug delivery technologies, including solid dosage from, oral-controlled... see more

Recent & Breaking News (OTCPK:SHMN)

SOHM, Inc. Signs MOU with London/Asia-Based Fund to Infuse Funds for Various Projects

Accesswire October 18, 2022

SOHM, Inc. Expands Advisory Board with Appointment of Dr. David Aguilar Ph.D., as its Expert Medical Advisor.

Accesswire March 2, 2022

SOHM, Inc. Announces the Appointment of Wm. Dewey Rushing, former US FDA Investigator to its Advisory Board

Accesswire February 23, 2022

SOHM, Inc., Collaborates for Commercial Manufacturing of Brainwise(R), a Patented Omega 3 Formula for Global Distribution

Accesswire November 30, 2021

SOHM, Inc. Signs Industry Expert Sivana Group as Strategic Consultant for Rebranding and Global Expansion

Accesswire November 15, 2021

SOHM, Inc., Announces Important Details of Its California Pharmaceutical Company Acquisition Expanding Manufacturing into the US Market

Accesswire November 11, 2021

SOHM, Inc., Signed a Definitive Agreement for Acquisition of Californian Pharmaceutical Company

Accesswire September 30, 2021

SOHM Receives Repeat New Order From Private Label Customer

Accesswire September 29, 2021

SOHM, Inc. Moves a Step Closer in Securing a Definitive Agreement in Previously Announced Proposed Acquisition of Southern California Based Pharmaceutical Company

Accesswire August 23, 2021

SOHM, Inc., Receives a Mandate for Development, Manufacturing, and Supply Two New topical products.

Accesswire August 4, 2021

SOHM Receives Semi-Annual Order From Private Label Customer to Boost Anticipated Revenue for 2021

Accesswire June 3, 2021

SOHM, Inc. Announce Company Outlook for the Year 2021 - Shareholder Updates

Accesswire May 18, 2021

SOHM, Inc., to Focus Growth on Rx-to-OTC Switches with Private Label Products

Accesswire May 12, 2021

SOHM, Inc., signs a Mutual Letter of Intent for an Acquisition of Southern California based Pharmaceutical Company

Accesswire April 27, 2021

Sohm, Inc., Announces Shares Buyback Program

Accesswire February 26, 2019

SOHM, Inc. Announce Share Holder Update and Outlook for 2019

Accesswire January 18, 2019

SOHM, Inc., Enters into Master Supply Agreement with US based Pharmaceutical Company

Accesswire January 7, 2019

NOTICE TO DISREGARD - SOHM, Inc.

GlobeNewswire August 9, 2018

SOHM, Inc. Subsidiary Daiichi Sankyo Group Files Its Acute Myeloid Leukemia (AML) Treatment Quizartinib in the US; the FDA Awarded Breakthrough Status for The Drug

GlobeNewswire August 9, 2018

SOHM, Inc. Announces Potential Purchase Orders for a Range of Pharmaceutical Products

GlobeNewswire August 2, 2018